Composition
Tab 0.125 mg: Methylergometrine maleate 0.125 mg. Inj: Per 1 ml amp: Methylergometrine maleate 0.2 mg.
Indications & Dosage
Management of puerperium, postpartum haemorrhage, uterine haemorrhage, uterine subinvolution, uterine atonia (Adjunct): By IV INJ: Adults: 0.5 ml IV or 1 ml IM after delivery of placenta. ORAL: Adults: 1 tab 3-times daily for three to four days in puerperium. Children: Not applicable.
Administration
IV: Ampoules containing discoloured solution should not be used: Administer over no less than 60 seconds.
Contraindications
Induction of labour, threatened spontaneous abortion, toxaemia, heart disease, labour augmentation, peripheral obliterative vascular disease, arteriovenous shunt, hypertention
Precautions
Caution in patients with sepsis, obliterative vascular disease.
Interactions
Antifungals, CYP3A4 inhibitors, sumatriptan, sibutramine and other serotonin agonists.
Side Effects
Vascular complications, ischemia, gangrene, coma, hypertension, angina, confusion, chest pain, palpi-tation, dizziness, hallucinations, seizures, headache, nausea, vomiting, diarrhoea, leg cramps, hematuria, dyspnoea, nasal congestion, tinnitus.